Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

1,038 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    USFDA Approves Sanofi's New Pediatric Vaccine For Six Diseases

    The first dose may be given as early as 6 weeks of age.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Bajaj Healthcare Files Compulsory License With Indian Patent Office For Baricitinib

    Baricitinib is essentially a drug approved in the US and European Union, for the treatment of rheumatoid arthritis.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
Article

Moral Rights Of Owner In Copyright Law Of India – A Paradigm Shift

Since time immemorial, India has been one of the most preferred sources of procuring products for sale in the market worldwide.
IndiaIntellectual Property
S.S. Rana & Co.
S.S. Rana & Co.
  • Article

    Pharmaceutical Industry & IPR In India: Balance Between Innovation & Access

    The pharmaceutical industry involves not only manufacturing and distribution but drug discovery, Research & Development ("R&D"), planning, mapping and pricing of lifesaving medications.
    IndiaIntellectual Property
    Naik Naik & Company
    Naik Naik & Company
  • Article

    Sun Pharma Gets Global License For CSIR-IICT'S Patents For New Drug Compounds

    On August 14, 2019, Sun Pharma and its subsidiaries announced that the company has entered into global licensing agreement with the CSIR Indian Institute of Chemical Technology
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Blowing Smoke; How Blinkit's Easy Cigarette Access Reveals Weak Law Enforcement

    In today's lightning-fast world, it's not just pizza that zooms to your door. Now, even cigarettes and tobacco products can be in your hands in a jaw-dropping nine minutes
    IndiaMedia, Telecoms, IT, Entertainment
    Naik Naik & Company
    Naik Naik & Company
  • Article

    To Fight COVID-19, Government Allows Manufacturers Of Industrial Oxygen To Produce Oxygen For Medical Use

    In a letter by the Drug Controller General of India (DCGI), released on April 7, 2020, stated that oxygen therapy is a part of clinical management of COVID-19 patients and therefore, it is of vital importance.
    IndiaCoronavirus (COVID-19)
    S&A Law Offices
    S&A Law Offices
  • Article

    CDSCO Extends The Last Date To Submit Application For FDCs Manufacturers

    On February 07, 2020, the Central Drugs Standard Control Organization (CDSCO) directed the manufacturers of Fixed-Dose Combination (FDCs) who are already holding the licenses from state drug...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Central Drugs Standard Control Organization (CDSCO)'s Marketing Approval Of Four Medicines In September 2017

    The Central Drugs Standard Control Organization (CDSCO), India, has approved four drugs in the month of September 2017.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Easing Compliance Burden: Analysis Of Revised FSSAI Licensing Thresholds

    The food safety regulatory landscape in India has undergone significant recalibration with the issuance of the Food Safety and Standards Authority of India Order dated March 13, 20...
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Interpreting Penal Provisions Strictly: High Court Ruling On Plant & Machinery Seizure Under FSSAI Act

    The regulatory landscape governing food safety in India, primarily anchored in the Food Safety and Standards Act, 2006, continues to witness judicial scrutiny to prevent administrative overreach.
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Legal Framework Governing Organic Food In India

    As per the Regulations the package of organic food should convey full and accurate information about the organic status.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    New Drug Approval: Regulatory Scenario In India

    Considering the Indian pharmaceutical industry is the third largest industry in terms of output, it is necessary to understand the regulatory scenario for the pharma sector...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lex Orbis
    Lex Orbis
  • Article

    Police Power Versus Food Safety Officer Jurisdiction : Rajasthan High Court Clears The Air In Ravi v. State Of Rajasthan

    A single-judge Bench of the Rajasthan High Court at Jaipur (Justice Anoop Kumar Dhand) has, on 19 November 2025, quashed FIR No. 160/2022 lodged at Police Station Sadar...
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Effect Of Registered Trademark In Food Industries GST

    MSME's having very small number of the resources, very less turnover they will not survive in the market competition with big industries.
    IndiaIntellectual Property
    Intellect Goodwill
    Intellect Goodwill
  • Article

    Product Patenting in the Indian Pharma Sector

    In the recent times the Indian pharma sector has been marked by dynamic changes. The Patent Act of 1970 as amended on March 22, 2005 marked the end of a protected era and has brought in a new phase in the integration of India into the global pharmaceutical market.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Sitagliptin Judgement: An Overview

    In a recent, very intensely contested litigation between Merck Sharp and Glenmark Pharmaceuticals Ltd., the Hon'ble Delhi High Court delivered a much awaited judgement. In the suit Merck contended infringement of its Anti-diabetic drug Sitagliptin ..
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Anti‐doping: The Indian Scenario

    Playing a vital role in the development of the overall personality of an individual, sports are an import facet of human life.
    IndiaMedia, Telecoms, IT, Entertainment
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    European Commission Approval To Rituximab Is First Biologic Treatment For A Rare Autoimmune Disease

    These cells are central to many blood cancers, including common forms of lymphoma and leukaemia.
    European UnionFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Suspension Of Fenspiride Medicines Due To Potential Risk Of Heart Rhythm Problems

    On January 15, 2019 EMA's Pharmacovigilance Risk Assessment Committee recommended an EU-wide suspension of fenspiride medicines due to the risk of QT prolongation and torsades de pointes ...
    European UnionFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Showing 121–140 of 1038 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics